Idera Pharmaceuticals Inc.

1.59+0.0400+2.58%Vol 179.22K1Y Perf -38.70%
Feb 14th, 2020 15:59
BID1.56 ASK1.65
Open1.57 Previous Close1.55
Pre-Market- After-Market1.65
 - -%  0.06 3.77%
Target Price
8.25 
Analyst Rating
Strong Buy 1.00
Potential %
418.87 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★     45.73
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
 —    -
Market Cap45.91M 
Earnings Rating
Strong Buy
Price Range Ratio 52W %
5.11 
Earnings Date
4th Mar 2020

Today's Price Range

1.521.65

52W Range

1.454.19

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-0.63%
1 Month
-26.05%
3 Months
-24.64%
6 Months
-25.35%
1 Year
-38.70%
3 Years
-88.58%
5 Years
-95.61%
10 Years
-95.91%

TickerPriceChg.Chg.%
IDRA1.590.04002.58
AAPL324.950.08000.02
GOOG1 520.746.08000.40
MSFT185.351.64000.89
XOM60.64-0.2900-0.48
WFC48.220.10000.21
JNJ150.130.04000.03
FB214.181.04000.49
GE12.83-0.1100-0.85
JPM137.46-0.4200-0.30
Earnings HistoryEstimateReportedSurprise %
Q03 2019-0.47-0.3917.02
Q02 2019-0.42-0.397.14
Q01 2019-0.46-0.4013.04
Q04 2018-0.49-0.458.16
Q03 2018-0.56-0.4617.86
Q02 2018-0.80-0.5926.25
Q01 2018-0.72-0.80-11.11
Q04 2017-0.64-0.640.00
Earnings Per EndEstimateRevision %Trend
12/2019 QR-0.330.00-
12/2019 FY-1.480.00-
3/2020 QR-0.350.00-
12/2020 FY-1.200.00-
Next Report Date4th Mar 2020
Estimated EPS Next Report-0.33
Estimates Count4
EPS Growth Next 5 Years %-
Volume Overview
Volume179.22K
Shares Outstanding28.87M
Trades Count478
Dollar Volume198.06K
Avg. Volume195.89K
Avg. Weekly Volume227.82K
Avg. Monthly Volume210.24K
Avg. Quarterly Volume235.91K
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
5 (100.00 %)
5 (100.00 %)
5 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Idera Pharmaceuticals Inc.

Idera Pharmaceuticals Inc is a clinical-stage biopharmaceutical company involved in the discovery, development, and commercialization of innovative therapeutics for oncology and rare diseases. The company has developed two distinct proprietary drug-discovery technology platforms: Toll-like receptor and third-generation antisense technology. The Toll-like receptor technology helped the company create synthetic oligonucleotide-based drug candidates. The 3GA technology is used to create drug candidates to turn off the RNA messengers associated with genes causing various diseases.

CEO: Vincent J. Milano

Teplephone: +1 484 348-1600

Address: 505 Eagleview Boulevard, Exton 19341, PA, USA

Number of employees: 36

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

33%67%

Bearish Bullish

50%50%

Bearish Bullish

44%56%

News

Stocktwits